Although RAS-MAPK signaling increases HSF1 phosphorylation and the activation of cancer development and progression through adaptation to cellular proteotoxic and metabolic stress [21,22,41], the correlation between HSF1 and cholesterol biosynthesis induced by oncogenic RAS-MAPK signaling during cancer development and progression has not been investigated. The gene discussed is HSF1; the disease is cancer.